ScripAlthough merger and acquisition activity in the South Korean biopharma sector is viewed as relatively timid compared to the global market, it seems to have increased notably since the end of the COVID
Medtech InsightThree former executives for Magellan Diagnostics are facing criminal charges in connection with the company’s distribution of faulty blood lead tests. Magellan’s LeadCare Ultra, LeadCare II and Lead
In VivoBiopharma Acquisitions Biopharma merger and acquisition value for the third quarter of 2022 reached $15.4bn from 41 transactions, 21 of which had disclosed values. Four M&A transactions hit or exceede
Medtech InsightMeridian Bioscience, Inc. said on 7 July it will be acquired by SD BioSensor, Inc. and SJL Partners in an all-cash deal valued at $1.53bn. “In addition to delivering immediate and significant value